Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>Events>This Event
  Events - November 2013

Clinical Trials in CNS

18 Nov 2013 - 19 Nov 2013 - London, UK

Bookmark and Share

SMi is proud to present the 12th Annual...

Clinical Trials in CNS

The highly anticipated and respected 12th annual Clinical Trials in CNS Conference returns to London with a two day content packed agenda featuring new approaches taken in this field towards a number of neurodegenerative disorders, from clinical trial modelling and simulation to the role of biomarkers, the agenda presents a detailed look into many aspects of drug discovery and delivery of CNS therapeutics. This innovative conference will give delegates an opportunity to gain insights through case studies and interactive discussion into the best practices in clinical trials. 

>>>>>Event highlights include:

Learn the importance of understanding the pathophysiology and biology of disease processes with use of biomarkers and imaging techniques

Discover ways to design late stage clinical trials

Overcome challenges of delivery within the CNS

Determine the legal and ethical issues behind sham surgery


Larry Alphs, Therapeutic Area Leader, Johnson & Johnson

Lars Bauer, Senior Medical Director TA CNS, UCB Pharma

Tom Isaacs, Co-founder, Cure Parkinson’s Trust

Kyriacos Mitrophanous, Head of Research, Oxford Biomedica

Mathieu Albasser, Post Doctoral Researcher, Eli Lilly 

Johannes Streffer, Senior Director, Experimental Medicine Europe, Janssen Research & Development

Warren Hirst, Associate Research Fellow Neurodegeneration Research, Pfizer

Eric Karran, Director of Research, Alzheimers Research UK



Defining Clinical Relevance

Workshop Leaders: Susan Mcgoldrick, Managing Director, QCTR

Audrey Jamieson, Business Development Manager, QCTR

08.30 - 12.30

**Book by 19th July 2013 and save £300**

**Book by 31st September 2013 and save £100**

Visit our website here:

Alternatively, contact: Jonathan Collins on +44 (0)20 7827 6734 or email:

Academic & Group discounts available

Further information
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
The MaxSignal Colistin ELISA Test Kit from Bioo Scientific
Kit can help prevent the antibiotic apocalypse by keeping last resort drugs out of the food supply.
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Closing the Loop on an HIV Escape Mechanism
Research team finds that protein motions regulate virus infectivity.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos